Learning Objectives
Upon completion of this activity, participants should be able to:
- Summarize the current DHHS recommendations on when to start antiretroviral therapy in treatment-naive HIV-infected individuals
- Describe data from observational cohorts that have suggested benefits to initiating therapy at CD4+ cell counts > 350 cells/mm3
- Discuss the potential risks and benefits of earlier initiation of antiretroviral therapy
Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.